Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Ung terapi i Sverige AB
AB
Active
Org 5593938698
Roslagsgatan 23 B Lgh 1201
Activities of psychologists and psychotherapists, except medical doctors · NACE 8693
Est. 2022
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 122K
+430% vs 2023
EBITDA margin
73.8%
+1842% vs 2023
Equity ratio
73.6%
Financial strength
Net profit 2024
SEK 71K
+1840% vs 2023
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 122K
+430%
EBITDA
SEK 90K
+1842%
Net profit
SEK 71K
+1840%
Total assets
SEK 136K
+236%
Equity
SEK 100K
+249%
Employees
0
—
Company information
Legal name
Ung terapi i Sverige AB
Org number
5593938698
Legal form
Aktiebolag
NACE code
8693 · Activities of psychologists and psychotherapists, except medical doctors
Founded
25 augusti 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna suppleanten
Company purpose
Företaget erbjuder terapisamtal och stöd med inriktning KBT.
Contact
Address
Roslagsgatan 23 B Lgh 1201
Email
jarnheimer95@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Activities of psychologists and psychotherapists, except medical doctors
Companies in Stockholm
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
Income statement
SEK thousands
Item
2023
2024
Revenue
23
122
Staff expenses
—
—
EBITDA
5
90
Depreciation & amort.
—
—
EBIT
5
90
Net financials
—
−0
Profit before tax
5
90
Tax
−1
−19
Net profit
4
71
Balance sheet
SEK thousands
Item
2023
2024
Total assets
41
136
Equity
29
100
Long-term debt
—
—
Short-term debt
12
36
Total debt
12
36
Financial ratios
5-year trend
EBITDA margin
73.8%
This company
15.8%
Market median
+367% vs market
2023
2024
Equity ratio
73.6%
This company
38.2%
Market median
+93% vs market
2023
2024
Return on equity
71.3%
This company
18.4%
Market median
+288% vs market
2023
2024
Net profit margin
58.5%
This company
8.1%
Market median
+622% vs market
2023
2024
Asset turnover
0.90×
This company
1.12×
Market median
+20% vs market
2023
2024
Debt / equity
0.36×
This company
0.62×
Market median
+42% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-08-25 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
AS
Anna Sofia Vendela Jarnheimer
Chief Executive Officer
Chief Executive Officer
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
VH
Viktor Hugo Caecar Jarnheimer
Chairman
2022
AL
Anton Ludwig Napoleon Jarnheimer
Deputy Board Member
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Ung terapi i Sverige AB also hold positions in
0
other companies.
Person
Role here
Other companies
Anna Sofia Vendela Jarnheimer
Chief Executive Officer
0 companies
Viktor Hugo Caecar Jarnheimer
Chairman
0 companies
Anton Ludwig Napoleon Jarnheimer
Deputy Board Member
0 companies